Weinmann Stefan, Wiedmann Simon, Breidert Tilo, Bohe Matthias, Pfeiffer Jan, Rosenberger Eva, Bechdolf Andreas
Kliniken für Psychiatrie, Psychotherapie und Psychosomatik, Vivantes Klinikum Am Urban und Vivantes Klinikum im Friedrichshain, Akademische Lehrkrankenhäuser der Charité Medizin, Berlin.
Universitäre Psychiatrische Kliniken, Basel, Schweiz.
Psychiatr Prax. 2019 Jul;46(5):249-255. doi: 10.1055/a-0881-1124. Epub 2019 Jul 3.
To investigate the clinical effectiveness of "Home Treatment" (HT) together with intensive outpatient treatment (IAB) in comparison to the usual psychiatric inpatient treatment.
In a retrospective controlled pre-post-study 83 patients receiving HT plus IAB were matched with 83 patients receiving inpatient treatment as usual. Routine data were compared with regard to length of stay and hospital readmission rate in a follow-up period of 6 and 12 months respectively.
There was no significant reduction of the length of stay of the first hospital admission. However, there was a significant, notable reduction with regard to length of stay and hospital readmission rate in the intervention group in a follow-up period of 6 and 12 months respectively.
HT plus intensive outpatient treatment is an effective complement to the usual psychiatric inpatient treatment. It can reduce the risk of hospital readmission and the length of stay for eligible patients.
探讨“家庭治疗”（HT）联合强化门诊治疗（IAB）与常规精神科住院治疗相比的临床疗效。
在一项回顾性对照前后研究中，将83例接受HT加IAB治疗的患者与83例接受常规住院治疗的患者进行匹配。分别比较了6个月和12个月随访期内的常规数据，包括住院时间和再入院率。
首次住院的住院时间没有显著缩短。然而，在6个月和12个月的随访期内，干预组的住院时间和再入院率分别有显著、明显的降低。
HT联合强化门诊治疗是常规精神科住院治疗的有效补充。它可以降低符合条件患者的再入院风险和住院时间。
Zotero 插件